rhod-2 has been researched along with to-pro-3 in 1 studies
Studies (rhod-2) | Trials (rhod-2) | Recent Studies (post-2010) (rhod-2) | Studies (to-pro-3) | Trials (to-pro-3) | Recent Studies (post-2010) (to-pro-3) |
---|---|---|---|---|---|
107 | 0 | 21 | 50 | 0 | 20 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dranoff, JA; Gores, GJ; Kruglov, EA; Minagawa, N; Nathanson, MH; Robert, ME | 1 |
1 other study(ies) available for rhod-2 and to-pro-3
Article | Year |
---|---|
The anti-apoptotic protein Mcl-1 inhibits mitochondrial Ca2+ signals.
Topics: Adenocarcinoma; Aniline Compounds; Antibodies, Monoclonal; Apoptosis; Bile Duct Neoplasms; Calcium Signaling; Carbocyanines; Cell Line; Cell Line, Tumor; Cell Nucleus; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Heterocyclic Compounds, 3-Ring; Humans; Hydrazines; Immunohistochemistry; Microscopy, Confocal; Mitochondria; Models, Biological; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tissue Distribution; Xanthenes | 2005 |